A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosis in pancreatic cancer.
Zhang P, Cao M, Zhang Y, Xu L, Meng F, Wu X, Xia T, Chen Q, Shi G, Wu P, Chen L, Lu Z, Yin J, Cai B, Cao S, Miao Y, Jiang K.
Zhang P, et al. Among authors: xia t.
J Cell Mol Med. 2020 Sep;24(18):10898-10912. doi: 10.1111/jcmm.15718. Epub 2020 Aug 8.
J Cell Mol Med. 2020.
PMID: 32770626
Free PMC article.